(XTLB) Xtl Biopharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Xtl Biopharmaceuticals | (XTLB) share price targets
Complete technical analysis of Xtl Biopharmaceuticals (XTLB) by charts plus indicators, forecast predictions and share price targets for Xtl Biopharmaceuticals (XTLB)
Xtl Biopharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-08-14 View latest technical analysis
10 day averaged volume of Xtl Biopharmaceuticals is 14090
| Date | Daily Closing Price | Open | High | Low | Volume |
| 14 Thu Aug 2025 | 1.42 | 1.42 | 1.46 | 1.42 | 0.234 times |
| 13 Wed Aug 2025 | 1.42 | 1.42 | 1.47 | 1.42 | 0.234 times |
| 12 Tue Aug 2025 | 1.39 | 1.41 | 1.42 | 1.33 | 0.696 times |
| 11 Mon Aug 2025 | 1.48 | 1.36 | 1.48 | 1.32 | 0.248 times |
| 08 Fri Aug 2025 | 1.36 | 1.39 | 1.39 | 1.35 | 0.83 times |
| 07 Thu Aug 2025 | 1.42 | 1.45 | 1.45 | 1.38 | 0.525 times |
| 06 Wed Aug 2025 | 1.39 | 1.41 | 1.64 | 1.39 | 4.244 times |
| 05 Tue Aug 2025 | 1.45 | 1.59 | 1.59 | 1.40 | 1.036 times |
| 01 Fri Aug 2025 | 1.39 | 1.40 | 1.54 | 1.39 | 0.816 times |
| 31 Thu Jul 2025 | 1.40 | 1.56 | 1.56 | 1.40 | 0.532 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 1.4 as stoploss in an intra day buy trade for a target of 1.58. However, stock will show a bearish move below 1.4.
Share price targets for Xtl Biopharmaceuticals (XTLB)
| Target Type | Value |
| Downside Target | 0.86 |
| Downside Target | 0.92 |
| Downside Target | 0.99 |
| Downside Target | 1.14 |
| Downside Target | 1.32 |
| Downside Target | 1.39 |
| Upside Target | 1.48 |
| Upside Target | 1.60 |
| Upside Target | 1.64 |
| Upside Target | 1.68 |
| Upside Target | 1.72 |
| Upside Target | 1.78 |
| Upside Target | 1.88 |
| Upside Target | 1.89 |
Intraday share price targets for Xtl Biopharmaceuticals (XTLB)
| Target Type | Value |
| Downside Intraday Target | 1.33 |
| Downside Intraday Target | 1.25 |
| Upside Intraday Target | 1.49 |
| Upside Intraday Target | 1.57 |
| Downside Intraday Target | 1.41 |
Weekly technical analysis of Xtl Biopharmaceuticals (XTLB)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 14 Thu Aug 2025 | 1.42 | 1.36 | 1.48 | 1.32 | 0.213 times |
| 08 Fri Aug 2025 | 1.36 | 1.59 | 1.64 | 1.35 | 1.956 times |
| 01 Fri Aug 2025 | 1.39 | 1.65 | 1.78 | 1.39 | 0.213 times |
| 25 Fri Jul 2025 | 1.75 | 1.71 | 1.89 | 1.60 | 1.307 times |
| 18 Fri Jul 2025 | 1.76 | 1.33 | 1.88 | 1.33 | 1.254 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Xtl Biopharmaceuticals (XTLB)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 14 Thu Aug 2025 | 1.42 | 1.40 | 1.64 | 1.32 | 0.193 times |
| 31 Thu Jul 2025 | 1.40 | 1.15 | 1.89 | 1.14 | 0.459 times |
| 30 Mon Jun 2025 | 1.14 | 1.25 | 1.72 | 0.86 | 6.38 times |
| 30 Fri May 2025 | 1.20 | 1.47 | 1.74 | 0.99 | 1.292 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Xtl Biopharmaceuticals (XTLB)
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Xtl Biopharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Xtl Biopharmaceuticals in short term and the sell signal is strong.
Xtl Biopharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Xtl Biopharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Xtl Biopharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.4 and Xtl Biopharmaceuticals (XTLB) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Xtl Biopharmaceuticals (XTLB) stock. Volume based technical analysis of Xtl Biopharmaceuticals (XTLB) stock is negative.
Xtl Biopharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Xtl Biopharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Xtl Biopharmaceuticals in short term and the sell signal is strong.
Xtl Biopharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Xtl Biopharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Xtl Biopharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.4 and Xtl Biopharmaceuticals (XTLB) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Xtl Biopharmaceuticals (XTLB) stock. Volume based technical analysis of Xtl Biopharmaceuticals (XTLB) stock is negative.
Xtl Biopharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.